MedPath
HSA Product

ELLA TABLET 30MG

Product approved by Health Sciences Authority (SG)

Basic Information

ELLA TABLET 30MG

TABLET

Regulatory Information

SIN13979P

June 21, 2011

Prescription Only

Therapeutic

ORAL

August 10, 2023

May 30, 2025

XG03AD02

Company Information

CENEXI

HYPHENS PHARMA PTE. LTD.

HYPHENS PHARMA PTE. LTD.

Active Ingredients

Ulipristal acetate

Strength: 30.00 mg

Detailed Information

Contraindications

**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. Pregnancy.

Indication Information

**4.1 Therapeutic indications** Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.

© Copyright 2025. All Rights Reserved by MedPath